S
Science 37
Uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials
At a glance
- Status
- Listed
- Listing
- Public via SPAC 2021
News
Open roles
Science 37 in the Morrisville ecosystem
The Science 37 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Lux Capital- DCdRx Capital
Series B and later11 investors entered at this stage
- AMAmgen
- LBLA BioMed
- AVAmgen Ventures
Glynn Capital Management
Mubadala Capital- PPPPD
- SVSanofi Ventures
- LPLifeSci Venture Partners
- SBSanofi-Genzyme BioVentures
- RGRedmile Group
- NONovartis
Source: Dealroom Talent Intelligence.
Alumni founders
Former Science 37 employees who went on to found companies, sorted by Dealroom signal score.
Belinda TanUnited States
PAPeer AIEst. 2023
Anita ModiUnited States
Kelly ChuUnited States
ABAltis BiosystemsEst. 2015
Michael BironUnited StatesSee Science 37 on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

